New data show that pre-diabetes and impaired beta cell function were associated with a dysfunctional gut barrier, a potential precursor to metabolic diseases Additional analysis of the company’s pivotal GLOW study suggests fasting plasma glucose levels and insulin resistance could be strong predictors of weight loss with Plenity® New in-vitro beverage interaction study finds that … Continue reading Gelesis Presents Three Poster Presentations at ObesityWeek® 2020